An Israeli medtech company is using artificial intelligence to help oncologists decide the best and most effective course of treatment for their cancer patients.
Read more here.
![[CytoReason in NoCamels] cytoreason teams up with merck kgaa on cancer drug development](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[CytoReason in NoCamels] cytoreason teams up with merck kgaa on cancer drug development
October 21, 2021
[Zoomcar in YourStory] Zoomcar’s Greg Moran, on what is driving ZAP Subscribe, and how the path to profitability is not always linear
February 10, 2018
